Blade announces earlier than expected spring timeline for re-launch of its $195 / seat New York City airport transfer product and the start of service between the Westchester/Connecticut area and both Manhattan and John F. Kennedy AirportStrategic Alliance with Ross Aviation will enable improved unit economics and flier experience on new Westchester routes including Manhattan and John F. Kennedy AirportBlade is actively working with Ross Aviation to plan for the construction of a dedicated EVA vertiport, including charging infrastructure, in WestchesterAlliance with Vertiport Chicago (to be rebranded Vertiport Chicago Powered by Blade) will enable further growth of our MediMobility organ transportation business as well as new passenger routes around the third largest city in the United StatesBlade India Joint Venture re-launched service between Mumbai and Pune in November 2020 with nearly 700 seats flown in the three months through January 2021 and 64% of fliers taking more than one trip in the periodBusiness combination with Experience Investment Corp. (NASDAQ: EXPC and EXPCW) expected to close in the first half of calendar year 2021
First fiscal quarter 2021 total revenues increased 53% versus the prior-year period to $8.0 million, despite the lack of contribution from Blade’s short-distance by-the-seat airport service, which remained paused in the first fiscal quarter due to the COVID-19 pandemicMediMobility (organ transport) and jet revenues grew 176% year-over-year as Blade added new customers, including additional hospital partnersShort-distance revenues declined 31% year-over-year, reflecting the impact of airport and West Coast short-distance services, which were paused in the first fiscal quarter 2021 due to the COVID-19 pandemic, partially offset by growth in our Northeast commuter businessHybrid remote/office work patterns drove increased demand for our Northeast Commuter services, with Blade offering daily round-trip services in the first fiscal quarter 2021 versus one round-trip per week in the prior-year period. This wider distribution of our schedule, in contrast to the typical weekend-focused compacted demand, resulted in increased flexibility for both our passengers and operatorsEBITDA improved $2.4 million year-over-year to ($2.2) million, and Adjusted EBITDA improved $3.6 million year-over-year to $(1.0) million, driven by increased revenues and the Company’s cost savings plan, implemented in April 2020 in response to the COVID-19 pandemic
BLADE URBAN AIR MOBILITY, INC. |
||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(unaudited) |
||||||||||||||||
(in thousands, except share and per share data) |
||||||||||||||||
For the Three Months
|
For the Year Ended
|
|||||||||||||||
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
||
Revenue |
$ |
7,986 |
|
$ |
5,223 |
|
$ |
23,434 |
|
$ |
31,196 |
|
||||
Operating expenses |
||||||||||||||||
Cost of revenue |
|
6,322 |
|
|
5,757 |
|
|
21,107 |
|
|
26,497 |
|
||||
Software development |
|
186 |
|
|
230 |
|
|
861 |
|
|
751 |
|
||||
General and administrative |
|
3,411 |
|
|
3,008 |
|
|
9,292 |
|
|
10,476 |
|
||||
Selling and marketing |
|
435 |
|
|
1,032 |
|
|
2,533 |
|
|
5,013 |
|
||||
Total operating expenses |
|
10,354 |
|
|
10,027 |
|
|
33,793 |
|
|
42,737 |
|
||||
Loss from operations |
|
(2,368 |
) |
|
(4,804 |
) |
|
(10,359 |
) |
|
(11,541 |
) |
||||
Other non-operating income |
||||||||||||||||
Interest income |
|
7 |
|
|
91 |
|
|
200 |
|
|
718 |
|
||||
Interest expense |
|
- |
|
|
- |
|
|
(1 |
) |
|
(15 |
) |
||||
Total other non-operating income |
|
7 |
|
|
91 |
|
|
199 |
|
|
703 |
|
||||
Net loss |
$ |
(2,361 |
) |
$ |
(4,713 |
) |
$ |
(10,160 |
) |
$ |
(10,838 |
) |
||||
BLADE URBAN AIR MOBILITY, INC. |
||||||||||||||
DISAGGREGATED REVENUE BY PRODUCT LINE |
||||||||||||||
(unaudited) |
||||||||||||||
(In thousands) |
||||||||||||||
For the Three Months Ended
|
For the Year Ended
|
|||||||||||||
Product Line |
2020 |
2019 |
2020 |
2019 |
||||||||||
Short Distance flight services |
$ |
2,186 |
$ |
3,167 |
$ |
9,941 |
$ |
26,017 |
||||||
MediMobility organ transplant and jet |
|
5,229 |
|
1,893 |
|
12,785 |
|
4,965 |
||||||
Other |
|
571 |
|
163 |
|
708 |
|
214 |
||||||
Total Revenue |
$ |
7,986 |
$ |
5,223 |
$ |
23,434 |
$ |
31,196 |
||||||
BLADE URBAN AIR MOBILITY, INC. |
||||||||||||||||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES |
||||||||||||||||||
(In thousands) |
||||||||||||||||||
For the Three Months
|
For the Year Ended
|
|
||||||||||||||||
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
|
||||||
Reconciliation of Net Loss to EBITDA(1) and Adjusted EBITDA(2) |
|
|||||||||||||||||
Net Loss |
$ |
(2,361 |
) |
$ |
(4,713 |
) |
$ |
(10,160 |
) |
$ |
(10,838 |
) |
|
|||||
Interest Income, net |
|
(7 |
) |
|
(91 |
) |
|
(199 |
) |
|
(703 |
) |
|
|||||
Depreciation and Amortization Expense |
|
139 |
|
|
|
134 |
|
|
526 |
|
|
|
472 |
|
|
|||
EBITDA |
|
(2,229 |
) |
|
(4,670 |
) |
|
(9,833 |
) |
|
(11,069 |
) |
|
|||||
Stock- based Compensation Expense |
|
1,275 |
|
|
|
91 |
|
|
490 |
|
|
|
317 |
|
|
|||
Adjusted EBITDA |
$ |
(954 |
) |
|
$ |
(4,579 |
) |
$ |
(9,343 |
) |
|
$ |
(10,752 |
) |
|
(1) |
EBITDA is defined as net income (loss) before interest, taxes, depreciation and amortization. |
||
(2) |
For purposes of comparison to the projections disclosed in the investor presentation filed with the SEC on December 15, 2020 and in the Form S-4 filed on January 29, 2021, which excluded stock-based compensation, Blade defined Adjusted EBITDA as EBITDA excluding stock-based compensation. Once Blade becomes a public company, Blade may calculate Adjusted EBITDA using different adjustments to describe our operating results. |